HIMS Hims & Hers Health, Inc. Class A Common Stock
$22,19
Precio · May 20, 2026
Fundamentales a fecha de May 11, 2026
Rango 52S
$14–$70
15% of range
Calificación del Analista
HOLD
23 analysts
Precio Objetivo
$27
+21% upside
P/E (TTM)
63.7
ROE
23.3%
Margen de Beneficio Neto
5.5%
HIMS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$22.19
Capitalización Bursátil
—
P/E (TTM)
63.7
BPA (TTM)
$0.51
Ingresos (TTM)
$2.35B
Rendimiento div.
—
ROE
23.3%
Deuda/Capital
—
Rango 52S
$14 – $70
HIMS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$2.35B
2019-12-31
→
2025-12-31
BPA
$0.51
2019-12-31
→
2025-12-31
Flujo de caja libre
$57M
2024-12-31
→
2025-12-31
Márgenes
5.5%
2021-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
HIMS
Mediana de Pares
P/E (TTM)
63.7
51.7
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
HIMS
Mediana de Pares
Gross Margin (Margen Bruto)
73.8%
32.4%
Operating Margin (Margen Operativo)
4.5%
—
Net Profit Margin (Margen de Beneficio Neto)
5.5%
1.7%
ROA
9.0%
2.2%
ROE
23.3%
7.5%
ROIC
20.2%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
HIMS
Mediana de Pares
Current Ratio (Ratio corriente)
1.9
1.7
Quick Ratio (Ratio Rápido)
0.6
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
HIMS
Mediana de Pares
Revenue YoY (Ingresos interanuales)
59.0%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
64.5%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
73.6%
—
EPS YoY (EPS interanual)
-3.8%
—
Net Income YoY (Beneficio Neto interanual)
1.8%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
HIMS
Mediana de Pares
HIMS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
23 analistas
- Compra fuerte 2 8,7%
- Compra 8 34,8%
- Mantener 13 56,5%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
14 analistas · 2026-05-16
Mediana
$25.25
Media
$26.82
Ahora
$22.19
Mín
$18.00
Máx
$35.00
Objetivo mediano
$25.25
+13,8%
Objetivo medio
$26.82
+20,9%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.03%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.19 | $0.04 | -0.23% |
| 31 de diciembre de 2025 | $0.08 | $0.05 | 0.03% |
| 30 de septiembre de 2025 | $0.06 | $0.11 | -0.05% |
| 30 de junio de 2025 | $0.17 | $0.15 | 0.02% |
| 31 de marzo de 2025 | $0.20 | $0.12 | 0.08% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | — |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| BLLN | $0 | 584.6 | 100.0% | 2.4% | 6.5% | 68.3% |
| OPCH | $5.00B | 25.1 | 13.0% | 3.7% | 15.4% | 19.3% |
| CRVL | $5.75B | 61.2 | 12.6% | 10.6% | 30.6% | 23.4% |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872M | $527M | $272M | $149M | $83M | |
| Cost of Revenue | $614M | $303M | $157M | $118M | $67M | $39M | $38M | |
| Gross Profit | $1.73B | $1.17B | $715M | $409M | $204M | $109M | $45M | |
| SG&A Expense | $273M | $168M | $130M | $98M | $114M | $26M | $56M | |
| Operating Expenses | $1.63B | $1.11B | $744M | $477M | $320M | $125M | $119M | |
| Operating Income | $106M | $62M | $-29M | $-69M | $-115M | $-15M | $-74M | |
| Interest Expense | · | · | · | · | $0 | $10.0K | $369.0K | |
| Interest Income | · | · | · | · | · | $3M | · | |
| Other Non-op | $23M | $10M | $9M | $3M | $445.0K | $258.0K | $2M | |
| Pretax Income | $124M | $72M | $-22M | $-66M | $-111M | $-18M | $-72M | |
| Income Tax | $-4M | $-54M | $2M | $-31.0K | $-3M | $127.0K | $90.0K | |
| Net Income | $128M | $126M | $-24M | $-66M | $-108M | $-18M | $-72M | |
| EPS (Basic) | $0.57 | $0.58 | $-0.11 | $-0.32 | $-0.58 | $-0.51 | $-2.07 | |
| EPS (Diluted) | $0.51 | $0.53 | $-0.11 | $-0.32 | $-0.58 | $-0.51 | $-2.07 | |
| Shares (Basic) | 224,959,268 | 215,939,037 | 209,344,712 | 204,516,120 | 186,781,537 | 35,353,809 | 34,758,817 | |
| Shares (Diluted) | 258,230,547 | 236,808,876 | 209,344,712 | 204,516,120 | 186,781,537 | 35,353,809 | 34,758,817 | |
| EBITDA | $160M | $79M | $-20M | $-61M | $-111M | · | · |
Balance general 25
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $229M | $221M | $97M | $47M | $72M | $27M | $2M | |
| Receivables | $32M | $6M | $7M | $4M | $4M | $1M | · | |
| Inventory | $80M | $64M | $22M | $22M | $14M | $4M | · | |
| Prepaid Expense | $78M | $31M | $22M | $15M | $9M | $5M | $147.5K | |
| Other Current Assets | $4M | $400.0K | $4M | $2M | $890.0K | $2M | · | |
| Current Assets | $768M | $396M | $265M | $217M | $270M | $113M | $2M | |
| PP&E (Net) | · | · | · | $3M | $2M | $2M | · | |
| Accum. Depreciation | $53M | $24M | $12M | $6M | · | · | · | |
| Goodwill | $278M | $113M | $111M | $111M | $111M | $0 | · | |
| Intangibles | $196M | $43M | $19M | $22M | $26M | $59.0K | · | |
| Other Non-current Assets | $30M | $147.0K | $91.0K | $33.0K | $8M | $5M | · | |
| Total Assets | $2.15B | $708M | $441M | $366M | $421M | $119M | $205M | |
| Accounts Payable | $143M | $91M | $43M | $32M | $20M | $8M | $18.5K | |
| Accrued Liabilities | $79M | $53M | $29M | $12M | $12M | $5M | $478.6K | |
| Current Liabilities | $404M | $221M | $88M | $48M | $79M | $15M | $979.4K | |
| Capital Leases | $143M | $9M | $9M | $4M | $4M | $0 | · | |
| Deferred Tax | $29M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | $12M | $0 | $22.0K | $35.0K | $629.0K | $381.0K | · | |
| Total Liabilities | $1.61B | $231M | $97M | $55M | $86M | $16M | $8M | |
| Common Stock | $23.0K | $22.0K | $21.0K | $21.0K | $20.0K | $5.0K | · | |
| Paid-in Capital | · | · | · | · | · | $7M | $4M | |
| Retained Earnings | $-114M | $-242M | $-368M | $-345M | $-279M | $-171M | $1M | |
| AOCI | $2M | $-324.0K | $-124.0K | $-277.0K | $-137.0K | $-11.0K | · | |
| Stockholders' Equity | $541M | $477M | $344M | $312M | $335M | $-147M | $-140M | |
| Liabilities + Equity | $2.15B | $708M | $441M | $366M | $421M | $119M | $205M |
Flujo de Efectivo 16
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $55M | $17M | $10M | $7M | $4M | $1M | $260.0K | |
| Stock-based Comp | $135M | $92M | $66M | $43M | $67M | $6M | $8M | |
| Deferred Tax | $-13M | $-62M | $-13.0K | $-594.0K | $-3M | $0 | $0 | |
| Amort. of Intangibles | $24M | $4M | $4M | $4M | $2M | $100.0K | $100.0K | |
| Other Non-cash | $-5M | $77M | $21M | $-11M | $5M | · | · | |
| Operating Cash Flow | $300M | $251M | $73M | $-27M | $-34M | $-2M | $-75M | |
| CapEx | $243M | $53M | $26M | $7M | · | · | · | |
| Investing Cash Flow | $-1.02B | $-19M | $-12M | $35M | $-156M | $-40M | $-39M | |
| Debt Issued | · | · | · | · | $0 | $0 | $2M | |
| Net Debt Issued | · | · | · | $0 | $0 | · | · | |
| Stock Repurchased | $90M | $83M | $2M | $0 | $0 | $0 | $0 | |
| Net Stock Activity | $-90M | $-83M | $-2M | $0 | $-22M | · | · | |
| Financing Cash Flow | $730M | $-108M | $-11M | $-33M | $235M | $48M | $95M | |
| Net Change in Cash | $7M | $124M | $50M | $-25M | $44M | $6M | $-19M | |
| Taxes Paid | $23M | $8M | $1M | · | · | · | · | |
| Free Cash Flow | $57M | $198M | · | · | · | · | · |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% | · | · | |
| Operating Margin | 4.5% | 4.2% | -3.4% | -13.0% | -42.3% | · | · | |
| Net Margin | 5.5% | 8.5% | -2.7% | -12.5% | -39.6% | · | · | |
| Pretax Margin | 5.3% | 4.9% | -2.5% | -12.5% | -40.8% | · | · | |
| EBITDA Margin | 6.8% | 5.3% | -2.3% | -11.6% | -40.8% | · | · | |
| ROA | 9.0% | 21.9% | -5.8% | -16.7% | -39.9% | · | · | |
| ROE | 23.3% | 27.5% | -7.0% | -21.1% | -31.2% | · | · | |
| ROIC | 20.2% | 22.8% | -9.3% | -22.0% | -33.4% | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.8 | 3.0 | 4.5 | 3.4 | · | 1.7 | |
| Quick Ratio | 0.6 | 1.0 | 1.2 | 1.1 | 1.0 | · | 1.5 |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 2.6 | 2.2 | 1.3 | 1.0 | · | · | |
| Inventory Turnover | 8.5 | 7.0 | 7.1 | 6.7 | 7.9 | · | · | |
| Receivables Turnover | 122.9 | 230.7 | 164.5 | 131.7 | 104.6 | · | · |
Tasas de Crecimiento 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 59.0% | 69.3% | 65.5% | 93.8% | 82.8% | · | · | |
| Revenue CAGR 3Y | 64.5% | 75.8% | 80.3% | · | · | · | · | |
| Revenue CAGR 5Y | 73.6% | · | · | · | · | · | · | |
| EPS YoY | -3.8% | · | · | · | · | · | · | |
| Net Income YoY | 1.8% | · | · | · | · | · | · |
Valoración (TTM) 4
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.35B | $1.48B | $872M | $527M | $272M | $149M | $83M | |
| Net Income TTM | $128M | $126M | $-24M | $-66M | $-108M | $-18M | $-72M | |
| P/E | 63.7 | 45.6 | -80.9 | -20.0 | -11.3 | -28.6 | -4.8 | |
| Earnings Yield | 1.6% | 2.2% | -1.2% | -5.0% | -8.8% | -3.5% | -20.9% |
Estado de resultados 15
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $608M | $618M | $599M | $545M | $586M | $481M | $402M | $316M | $278M | $247M | $227M | $208M | $191M | $167M | $145M | $114M | |
| Cost of Revenue | $211M | $173M | $157M | $129M | $155M | $112M | $84M | $59M | $49M | $43M | $39M | $38M | $37M | $35M | $30M | $26M | |
| Gross Profit | $397M | $444M | $442M | $416M | $431M | $370M | $318M | $257M | $229M | $204M | $187M | $170M | $153M | $132M | $114M | $87M | |
| SG&A Expense | $110M | $76M | $81M | $67M | $49M | $48M | $45M | $41M | $35M | $32M | $36M | $31M | $31M | $28M | $26M | $23M | |
| Operating Expenses | $475M | $435M | $430M | $389M | $373M | $351M | $296M | $246M | $219M | $204M | $196M | $179M | $165M | $144M | $134M | $107M | |
| Operating Income | $-78M | $9M | $12M | $27M | $58M | $19M | $22M | $11M | $10M | $-400.0K | $-9M | $-9M | $-11M | $-12M | $-20M | $-20M | |
| Other Non-op | $4M | $6M | $8M | $6M | $3M | $4M | $1M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $677.0K | $402.0K | |
| Pretax Income | $-102M | $18M | $12M | $33M | $60M | $22M | $24M | $13M | $12M | $2M | $-7M | $-7M | $-10M | $-11M | $-19M | $-20M | |
| Income Tax | $-9M | $-2M | $-4M | $-10M | $11M | $-4M | $-52M | $127.0K | $1M | $951.0K | $651.0K | $-13.0K | $386.0K | $-121.0K | $-16.0K | $12.0K | |
| Net Income | $-92M | $21M | $16M | $43M | $49M | $26M | $76M | $13M | $11M | $1M | $-8M | $-7M | $-10M | $-11M | $-19M | $-20M | |
| EPS (Basic) | $-0.40 | $0.09 | $0.07 | $0.19 | $0.22 | $0.12 | $0.35 | $0.06 | $0.05 | $0.01 | $-0.04 | $-0.03 | $-0.05 | $-0.05 | $-0.09 | $-0.10 | |
| EPS (Diluted) | $-0.40 | $0.08 | $0.06 | $0.17 | $0.20 | $0.10 | $0.32 | $0.06 | $0.05 | $0.01 | $-0.04 | $-0.03 | $-0.05 | $-0.05 | $-0.09 | $-0.10 | |
| Shares (Basic) | 228,357,303 | -447,750,249 | 226,346,815 | 224,373,375 | 221,989,327 | -428,748,235 | 216,617,143 | 214,618,037 | 213,452,092 | -416,353,092 | 210,134,681 | 208,422,825 | 207,140,298 | -407,362,352 | 205,232,967 | 203,949,535 | |
| Shares (Diluted) | 228,357,303 | -493,834,687 | 248,675,710 | 256,779,292 | 246,610,232 | -462,417,233 | 235,069,539 | 234,791,985 | 229,364,585 | -416,353,092 | 210,134,681 | 208,422,825 | 207,140,298 | -407,362,352 | 205,232,967 | 203,949,535 | |
| EBITDA | $-56M | · | $12M | $27M | $66M | · | $22M | $11M | $13M | · | $-9M | $-9M | $-9M | · | $-20M | $-20M |
Balance general 23
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $222M | $229M | $346M | $1.12B | $274M | $221M | $166M | $129M | $105M | $97M | $58M | $65M | $49M | $47M | $58M | $55M | |
| Receivables | $150M | $32M | · | · | · | $6M | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $79M | $80M | $106M | $142M | $76M | $64M | $49M | $41M | $30M | · | $22M | $21M | $21M | · | $22M | $20M | |
| Prepaid Expense | $66M | $110M | $110M | $69M | $48M | $31M | $23M | $23M | $28M | · | $16M | $20M | $20M | · | $13M | $16M | |
| Other Current Assets | $11M | $4M | $35M | $21M | $12M | $400.0K | $6M | $3M | $7M | · | $1M | $2M | $2M | · | $2M | $800.0K | |
| Current Assets | $1.05B | $768M | $845M | $1.36B | $447M | $396M | $326M | $291M | $262M | · | $250M | $235M | $226M | · | $233M | $230M | |
| Accum. Depreciation | $62M | $53M | $45M | $37M | $30M | $24M | $20M | $17M | $14M | · | $10M | · | · | · | · | · | |
| Goodwill | $343M | $278M | $259M | $118M | $118M | $113M | $113M | $111M | $111M | $111M | $111M | $111M | $111M | · | $111M | $111M | |
| Intangibles | $261M | $196M | $195M | $41M | $43M | $43M | $45M | $17M | $18M | · | $19M | $20M | $21M | · | $22M | $24M | |
| Other Non-current Assets | $48M | $30M | $4M | $2M | $2M | $147.0K | $138.0K | $138.0K | $138.0K | · | $72.0K | $19M | $14M | · | $10M | $9M | |
| Total Assets | $2.27B | $2.15B | $2.23B | $1.88B | $892M | $708M | $602M | $480M | $448M | · | $414M | $390M | $376M | · | $383M | $380M | |
| Accounts Payable | $307M | $143M | $198M | $105M | $109M | $91M | $75M | $57M | $44M | · | $42M | $38M | $38M | · | $33M | $27M | |
| Accrued Liabilities | $91M | $79M | $80M | $66M | $57M | $53M | $43M | $29M | $27M | · | $27M | $20M | $14M | · | $17M | $12M | |
| Current Liabilities | $619M | $404M | $451M | $272M | $280M | $221M | $153M | $109M | $93M | · | $83M | $67M | $56M | · | $67M | $56M | |
| Capital Leases | $152M | $143M | $144M | $72M | $60M | $9M | $10M | $10M | $10M | · | $3M | $3M | $3M | · | $4M | $3M | |
| Deferred Tax | $24M | $29M | $31M | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $13M | $12M | $6M | $1M | $2M | $0 | $0 | $22.0K | $21.0K | · | $5.0K | $14.0K | $84.0K | · | $249.0K | $371.0K | |
| Total Liabilities | $1.82B | $1.61B | $1.65B | $1.31B | $342M | $231M | $162M | $119M | $104M | · | $85M | $70M | $64M | · | $72M | $61M | |
| Common Stock | $23.0K | $23.0K | $23.0K | $23.0K | $22.0K | $22.0K | $22.0K | $22.0K | $21.0K | · | $21.0K | $21.0K | $21.0K | · | $21.0K | $21.0K | |
| Retained Earnings | $-206M | $-114M | $-134M | $-150M | $-193M | $-242M | $-268M | $-344M | $-357M | · | $-369M | $-362M | $-355M | · | $-334M | $-315M | |
| AOCI | $-4M | $2M | $921.0K | $822.0K | $-164.0K | $-324.0K | $229.0K | $-168.0K | $-162.0K | · | $-133.0K | $-258.0K | $-111.0K | · | $-462.0K | $-468.0K | |
| Stockholders' Equity | $446M | $541M | $581M | $563M | $549M | $477M | $440M | $362M | $344M | $344M | $329M | $320M | $313M | $312M | $311M | $319M | |
| Liabilities + Equity | $2.27B | $2.15B | $2.23B | $1.88B | $892M | $708M | $602M | $480M | $448M | · | $414M | $390M | $376M | · | $383M | $380M |
Flujo de Efectivo 15
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $18M | $18M | $10M | $8M | $6M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $37M | $34M | $40M | $36M | $25M | $24M | $25M | $24M | $19M | $18M | $17M | $17M | $14M | $12M | $11M | $11M | |
| Deferred Tax | $-14M | $-3M | $862.0K | $-9M | $-890.0K | $-7M | $-54M | $1.0K | $-1.0K | $17.0K | $-10.0K | $-69.0K | $49.0K | $-214.0K | $-122.0K | $-146.0K | |
| Amort. of Intangibles | $12M | $10M | $9M | $3M | $2M | $1M | $900.0K | $800.0K | $700.0K | $700.0K | $800.0K | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | $28M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $137M | · | · | · | $27M | · | · | · | $-7M | · | · | · | $3M | · | · | · | |
| Operating Cash Flow | $89M | $61M | $149M | $-19M | $109M | $86M | $85M | $54M | $26M | $22M | $25M | $17M | $9M | $-7M | $6M | $-6M | |
| CapEx | $36M | $64M | $69M | $50M | $59M | $27M | $6M | $6M | $14M | · | · | · | · | · | · | · | |
| Investing Cash Flow | $-15M | $-84M | $-887M | $-21M | $-33M | $-17M | $-10M | $-4M | $13M | $21M | $-31M | $2M | $-4M | $6M | $-3M | $13M | |
| Stock Repurchased | · | $80M | $9M | $0 | $0 | $5M | $30M | $20M | $28M | $2M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | · | · | · | $0 | · | · | · | $-28M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-78M | $-98M | $-39M | $889M | $-23M | $-14M | $-39M | $-25M | $-30M | $-4M | $-2M | $-3M | $-3M | $-10M | $-494.0K | $353.0K | |
| Net Change in Cash | $-6M | $-117M | $-779M | $850M | $54M | $55M | $36M | $24M | $9M | $39M | $-7M | $17M | $2M | $-11M | $3M | $7M | |
| Taxes Paid | $-7M | · | · | · | $360.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $53M | · | · | · | $50M | · | · | · | · | · | · | · | · | · | · | · |
Rentabilidad 8
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.2% | · | 73.8% | 76.4% | 73.5% | · | 79.2% | 81.3% | 82.4% | · | 82.6% | 81.8% | 80.4% | · | 79.0% | 76.8% | |
| Operating Margin | -12.9% | · | 2.0% | 4.9% | 9.9% | · | 5.6% | 3.5% | 3.6% | · | -3.8% | -4.4% | -5.9% | · | -13.8% | -17.8% | |
| Net Margin | -15.2% | · | 2.6% | 7.8% | 8.4% | · | 18.8% | 4.2% | 4.0% | · | -3.3% | -3.4% | -5.3% | · | -13.0% | -17.3% | |
| Pretax Margin | -16.7% | · | 2.0% | 6.0% | 10.3% | · | 5.9% | 4.2% | 4.5% | · | -3.0% | -3.5% | -5.1% | · | -13.0% | -17.3% | |
| EBITDA Margin | -9.3% | · | 2.0% | 4.9% | 11.3% | · | 5.6% | 3.5% | 4.6% | · | -3.8% | -4.4% | -4.8% | · | -13.8% | -17.8% | |
| ROA | -5.8% | · | 1.1% | 3.6% | 7.4% | · | 14.9% | 3.1% | 2.7% | · | -1.9% | -1.9% | -2.6% | · | -4.7% | -5.4% | |
| ROE | -18.5% | · | 3.1% | 9.2% | 11.1% | · | 19.7% | 3.9% | 3.4% | · | -2.4% | -2.2% | -3.1% | · | -5.7% | -6.4% | |
| ROIC | -15.9% | · | 2.6% | 6.1% | 8.6% | · | 16.3% | 3.0% | 2.6% | · | -2.9% | -2.9% | -3.7% | · | -6.4% | -6.3% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | · | 1.9 | 5.0 | 1.6 | · | 2.1 | 2.7 | 2.8 | · | 3.0 | 3.5 | 4.0 | · | 3.5 | 4.1 | |
| Quick Ratio | 0.6 | · | 0.8 | 4.1 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 0.7 | 1.0 | 0.9 | · | 0.9 | 1.0 |
Eficiencia 3
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | · | 0.4 | 0.5 | 0.9 | · | 0.8 | 0.7 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | |
| Inventory Turnover | 2.7 | · | 2.0 | 1.4 | 2.9 | · | 2.4 | 1.9 | 1.9 | · | 1.8 | 1.8 | 2.3 | · | 1.8 | 2.0 | |
| Receivables Turnover | 8.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 4
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.34B | · | $2.13B | $1.85B | $1.58B | · | $1.22B | $1.03B | $904M | · | $770M | $657M | $550M | · | $434M | $350M | |
| Net Income TTM | $16M | · | $183M | $181M | $149M | · | $92M | $10M | $-14M | · | $-44M | $-56M | $-65M | · | $-71M | $-61M | |
| P/E | 692.0 | · | 75.6 | 66.5 | 46.9 | · | 47.2 | 504.8 | -221.0 | · | -30.0 | -34.8 | -31.0 | · | -15.9 | -14.6 | |
| Earnings Yield | 0.14% | · | 1.3% | 1.5% | 2.1% | · | 2.1% | 0.20% | -0.45% | · | -3.3% | -2.9% | -3.2% | · | -6.3% | -6.8% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $2.35B | $1.48B | $872M | $527M | $272M |
| Margen Bruto % | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% |
| Margen Operativo % | 4.5% | 4.2% | -3.4% | -13.0% | -42.3% |
| Beneficio neto | $128M | $126M | $-24M | $-66M | $-108M |
| EPS Diluido | $0.51 | $0.53 | $-0.11 | $-0.32 | $-0.58 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 1.9 | 1.8 | 3.0 | 4.5 | 3.4 |
| Ratio Rápido | 0.6 | 1.0 | 1.2 | 1.1 | 1.0 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $57M | $198M | — | — | — |
Últimas noticias Noticias recientes que mencionan a esta empresa
- La masiva caída de acciones de Hims & Hers explicada
- Por qué las acciones de Hims & Hers Health se desplomaron
- Hims & Hers se desploma un 15% tras pérdidas en el primer trimestre y una débil previsión de beneficios
- Las acciones de Hims & Hers se hunden tras pérdida trimestral y no alcanzar ventas
- Las acciones de HIMS se desploman a medida que el cambio hacia los GLP-1 de marca afecta las perspectivas
- GoodRx vs. Hims & Hers Health: Estancamiento vs. Crecimiento en Ingresos
- BofA eleva el objetivo de Hims & Hers a $25 mientras la FDA da un paso hacia los péptidos de bienestar: ¿Se avecina un nuevo auge de ingresos?
- Mercado de Valores Hoy, 16 de abril: Hims & Hers Health Salta Gracias a la Revisión de la FDA de las Terapias Peptídicas Compuestas
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.